Microdosing GLP-1s means starting at significantly lower doses than standard guidelinessometimes as low as 0.05 to 0.1 mg of semaglutide per week, compared to the usual starting dose of 0.25 mg
The Precision Peptide Genetic Test reveals predispositions in peptide signaling pathways (GIPR, FTO, MC4R) that may provide contextbut does not predict exact response
In other words, these drugs act like the natural hormone GLP-1 and make your cells receptors send the exact same signal they would if they were binding to GLP-1 itself
Delayed Gastric Emptying (Again, a Key Player): As mentioned earlier, the slowed movement of food from the stomach not only helps regulate blood sugar but also prolongs the feeling of fullness, further aiding in calorie reduction
Abstract Background To estimate the long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin as an add-on therapy for type 2 diabetes patients inadequately controlled on metformin in China, to better inform healthcare decision making